Skip to content
Search

Latest Stories

Fatal fungus threat could expand globally due to climate change, warn researchers

The fungus can grow quickly in heat

Fatal fungus
Aspergillus species pose serious risks to human health and agriculture
iStock

A potentially deadly fungus that spreads rapidly and is resistant to treatment may become more widespread as global temperatures rise, according to new research.

The fungus, Aspergillus, is known to cause infections in humans, animals and plants. It thrives in warmer environments, and scientists now warn that climate change is creating more suitable conditions for its growth. The findings, based on a pre-print study from the University of Manchester, indicate that global warming could accelerate the spread of dangerous strains such as Aspergillus flavus and Aspergillus fumigatus.


The University of Manchester, which hosts the world’s largest centre for research into fungi and respiratory infections, stated in the report that Aspergillus species pose serious risks to human health and agriculture. Viv Goosens, research manager at the Wellcome Trust – which funded the study – told Sky News that fungal pathogens are already a concern, and climate change will make these risks worse. “To address these challenges, we must fill important research gaps,” she said.

The analysis suggests that by the year 2100, Aspergillus flavus, which affects crops, could expand its range by up to 16%. Meanwhile, Aspergillus fumigatus, a fungus that causes lung infections particularly in people with asthma or other underlying conditions, could increase its geographical spread by as much as 77%.

The U.S. Centers for Disease Control and Prevention identifies Aspergillus fumigatus as the leading cause of invasive mould infections in humans. The fungus causes a disease known as aspergillosis, which can be fatal and is often resistant to antifungal treatments. According to the CDC, patients infected with Aspergillus fumigatus are 33% more likely to die compared to those with treatable infections.

The fungus can grow quickly in heat, exacerbating the impact of global warming. Professor Elaine Bignell, co-director of the MRC Centre for Medical Mycology at Exeter University, told the Financial Times that the fungus develops “astonishingly quickly” in high temperatures.

Dr Norman van Rhijn, lead author of the study and a research fellow at the University of Manchester, warned that major shifts in the distribution of fungi could occur over the next few decades. “We’re talking about hundreds of thousands of lives, and continental shifts in species distributions,” he told the Financial Times. “In 50 years, where things grow and what you get infected by is going to be completely different.”

The research has drawn comparisons to the fictional fungal apocalypse portrayed in the popular series The Last of Us. However, Dr van Rhijn cautioned against viewing the findings as mere science fiction. “Reality is already scary enough,” he told Sky News.

Aspergillosis, the disease caused by inhaling fungal spores, can lead to symptoms such as fatigue, headaches, coughing up blood, and in severe cases, the infection can spread throughout the body. Scientists say that without further research and global mitigation efforts, fungal threats like Aspergillus could become increasingly difficult to control.

More For You

Mounjaro price rise

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro

iStock

Mounjaro’s highest dose to rise from £122 to £247.50, not £330

Highlights:

  • Eli Lilly had announced a steep price rise of up to 170% for Mounjaro.
  • A new discount deal with UK suppliers will limit the increase for patients.
  • Pharmacies will still apply a mark-up, but consumer costs are expected to rise less than initially feared.
  • NHS pricing remains unaffected due to separate arrangements.

Eli Lilly has agreed a discounted supply deal for its weight-loss drug Mounjaro, easing fears of a sharp rise in costs for UK patients. The new arrangement means that, from September, pharmacies and private services will face smaller wholesale increases than first expected, limiting the impact on consumers.

Why the price rise was announced

Earlier this month, Eli Lilly said it would raise Mounjaro’s list price by as much as 170%, which could have pushed the highest monthly dose from £122 to £330. The company argued that UK pricing needed to align more closely with higher costs in Europe and the United States.

Keep ReadingShow less
chicken-pox-istock

The Department of Health said the rollout would reduce missed days at nursery and school, cut time parents take off work, and save the NHS about £15 million a year. (Representational image: iStock)

iStock

England to introduce free chickenpox vaccine for children from 2026

CHILDREN in England will be offered a free chickenpox vaccine for the first time from January 2026, the government has announced.

GP practices will give eligible children a combined vaccine for measles, mumps, rubella and varicella (MMRV) as part of the routine childhood vaccination schedule. Around half a million children each year are expected to be protected.

Keep ReadingShow less
Naga Munchetty urges women to prioritise their health

Naga Munchetty

Naga Munchetty urges women to prioritise their health

WHEN broadcaster and journalist Naga Munchetty began speaking openly about her experiences with adenomyosis and debilitating menstrual pain, the response was overwhelming.

Emails and messages poured in from women who had endured years of dismissal, silence and shame when it came to their health. That outpouring became the driving force behind her new book, It’s Probably Nothing, which calls for women to be heard and to advocate for themselves in a medical system that has too often ignored them.

Keep ReadingShow less
Serena Williams

Williams explained that her weight challenges began after the birth of her first daughter

Getty Images

Serena Williams says GLP-1 made her feel light physically and mentally after 31lb loss

Highlights:

  • Serena Williams reveals she has lost more than 31lbs using a GLP-1 medication
  • The tennis legend says the treatment enhanced her existing healthy lifestyle
  • She stresses that weight loss should not change self-image or self-confidence

Serena Williams has revealed she has lost more than 31lbs after turning to a weight-loss medication, saying the treatment has transformed both her body and her mindset.

The 23-time Grand Slam champion, 43, told PEOPLE that using a GLP-1 medication — a type of injection that works by regulating appetite — has helped enhance the healthy lifestyle she already maintained through diet and exercise.

Keep ReadingShow less
Monica Seles

Seles first began noticing symptoms around five years ago

Getty Images

Tennis champion Monica Seles reveals living with myasthenia gravis

Highlights:

  • Nine-time Grand Slam winner Monica Seles diagnosed with myasthenia gravis three years ago
  • The 51-year-old revealed her condition ahead of this month’s US Open to raise awareness
  • Disease causes muscle weakness and has no known cure

Former world number one Monica Seles has revealed she was diagnosed with myasthenia gravis, a rare neuromuscular autoimmune disease, three years ago. The 51-year-old, who won nine Grand Slam singles titles, went public ahead of the US Open to raise awareness of the condition, which causes muscle weakness and can affect multiple parts of the body.

Symptoms and diagnosis

Seles first began noticing symptoms around five years ago when she experienced double vision and struggled with coordination. “I would be playing [tennis] with some kids or family members, and I would miss a ball. I was like, ‘Yeah, I see two balls,’” she told the Associated Press. These symptoms eventually led to her diagnosis, which took time for her to come to terms with.

Keep ReadingShow less